EMA, Possible Approval This Month for Pfizer Vaccine in Ages 12-15
[Asia Economy Reporter Yujin Cho] The European Medicines Agency (EMA) is expected to approve the use of the COVID-19 vaccine jointly developed by the American pharmaceutical company Pfizer and the German company BioNTech for individuals aged 12 to 15 as early as the end of this month.
On the 10th (local time), EMA Chief Emer Cook stated, "Our current goal is approval in June, but we are working to accelerate this to the end of May."
On the same day, the U.S. Food and Drug Administration (FDA) granted emergency use authorization for the Pfizer-BioNTech COVID-19 vaccine for minors aged 12 to 15.
Pfizer and BioNTech had announced on the 30th of last month that they requested the EMA to expand the authorized use of the COVID-19 vaccine to include those aged 12 to 15.
This vaccine is currently authorized for use in the EU for individuals aged 16 and older.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Chief Cook also commented on the issue of waiving intellectual property protections for the COVID-19 vaccine, stating that it would not solve the very serious problems posed by COVID-19.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
